{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"nad-plus","urls":{"read":"https://miscsubjects.com/api/articles/nad-plus/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/nad-plus/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/nad-plus/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/nad-plus/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/nad-plus/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/nad-plus/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/nad-plus/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"nad-plus","title":"nad plus","register":"standard","tags":[],"updated_at":"2026-07-17T02:40:37.925Z","body_excerpt":"## Overview\nEvidence is being populated by Grok web search.","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[],"sources":[{"id":"s1","type":"review","url":"https://pubmed.ncbi.nlm.nih.gov/37971292/","title":"Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review","quote":"This review includes 10 studies, with a total of 489 participants. ... NADH supplementation is safe and has a low incidence of side effects. Future investigations are needed to evidence the clinical benefits regarding specific diseases and doses administered.","summary":"2024 systematic review of RCTs on NAD+/NADH supplementation safety and efficacy across conditions like CFS, Parkinson's, Alzheimer's; concludes well-tolerated with some benefits in quality of life and parameters, low side effects.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"869513647d4f7588142f478728e329e0365fdb47c4097d349c753f32df3e7491"},{"id":"s2","type":"review","url":"https://pubmed.ncbi.nlm.nih.gov/41655607/","title":"NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence","quote":"We identified 113 eligible studies: 33 human intervention studies (28 randomized; 5 nonrandomized) and 80 rodent studies. ... Overall, NAD⁺ augmentation shows clear biological activity, but clinical effectiveness for anti-aging or wellness outcomes remains inconclusive.","summary":"2026 PRISMA systematic review of 113 studies (up to Oct 2025) on NAD+ precursors; strong preclinical effects, human trials show NAD boosting and tolerability but heterogeneous/inconclusive functional outcomes; calls for larger trials.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"822ba9e2aaf73280d08236720d9f832a0e3ee3a82123407d5eae116d49166b00"},{"id":"s3","type":"clinical_trial","url":"https://pubmed.ncbi.nlm.nih.gov/40479886/","title":"Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial","quote":"Preliminary results indicate a positive trend in peripheral endothelial function, significant improvements in cerebrovascular response in the left dorsolateral prefrontal cortex, and cognitive enhancement across multiple domains postsupplementation. ... These findings suggest that NR supplementation could ameliorate cognitive outcomes in older adults with PAD.","summary":"2025 pilot open-label trial (NCT06534944) of NR in 8 older PAD patients; showed trends/improvements in endothelial function, cerebrovascular responses, cognition, and in vitro endothelial benefits via reduced oxidative stress.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"a7eac5f034f16239c03d81c53c53248fddebba7aae23d702345e12aa1a77e5c6"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40954388/","title":"Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial","quote":"This study has confirmed that supplementation with NAD+ can enhance cardiac function in patients with from HF due to ICM, thereby affirming its beneficial impact on cardiac performance.","summary":"2026 RCT showing IV NAD+ improves LVEF and trends toward better outcomes in heart failure patients.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"157174255e4fcde7e87c20f630ec7e13746a109becc869b702de1747b9747c38"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41540253/","title":"The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans","quote":"Here we show in a randomized, open-label, placebo-controlled study in 65 healthy participants that 14 days of supplementation with NR and NMN, but not Nam, comparably increases circulatory NAD + concentrations in healthy adults.","summary":"2026 RCT comparing NR, NMN, and Nam effects on NAD levels and gut microbiota.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"e8af32efc5694522778f2a43384a68b781f822f1bc3a5be7610b71d54d109208"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41083806/","title":"NAD+ precursor supplementation in human ageing: clinical evidence and challenges","quote":"In this Review, we evaluate the clinical evidence supporting the notion that NAD + levels decline with age, as well as the tissue-specific effects of NAD + precursor supplementation in humans.","summary":"Recent review on clinical evidence for NAD+ precursors in aging.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"f6121f80d6ef9da89b1e4addb8a62c6f7ca188c454f1859a2b94f091dfe460d2"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41704678/","title":"Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting","quote":"Supplementation with NAD + and its precursors is commonly used to prevent age-related disease and extend healthspan.","summary":"2026 pilot study comparing IV NAD+ and NR tolerability.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"649a99782648d1dcc12c936eb9ea8870f24ca71ef7598348b79d1ee248e49abf"},{"id":"s8","type":"review","url":"https://pubmed.ncbi.nlm.nih.gov/39116016/","title":"Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials","quote":"Random-effects meta-analyses found an overall significant effect of NMN supplementation in elevating blood NAD levels. However, most of the clinically relevant ...","summary":"Systematic review and meta-analysis of RCTs on oral NMN for glucose and lipid metabolism in adults; shows NAD elevation but heterogeneous clinical outcomes.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"8b8b73b0fe3b838c4b95d9d4922ecdd4ef248375a0c6a15d5acd9f5167a98015"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39817194/","title":"Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment","quote":"Eight weeks NR supplementation is safe and lowered pTau 217 concentrations but did not alter cognition as measured by conventional or novel digital assessments.","summary":"Double-blind RCT showing 8 weeks NR safe, lowers AD biomarker pTau217, no cognitive change in older adults with SCD/MCI.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"fa06e720a34103e64fe25080eb218c55950cc759dbc473a9636a8d6f1bf359d6"},{"id":"s10","type":"clinical_trial","url":"https://pubmed.ncbi.nlm.nih.gov/40770531/","title":"Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial","quote":"This pilot randomized clinical trial (RCT) tested the efficacy of combining aerobic exercise with the NAD booster nicotinamide riboside (NR) to enhance BP ...","summary":"Pilot RCT of NR plus aerobic exercise for hypertension in middle-aged/older adults; tests efficacy for BP control.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"6c843db930a5bc943911b6b596d9262c48b6e8a04dacccf51850f6a49ea5fdd7"},{"id":"s11","type":"review","url":"https://pubmed.ncbi.nlm.nih.gov/39203931/","title":"NAD+ and Niacin Supplementation as Possible Treatments for Glaucoma and Age-Related Macular Degeneration: A Narrative Review","quote":"This review investigates the potential therapeutic benefits of NAD+ and niacin supplementation in managing glaucoma and AMD.","summary":"Narrative review on NAD+ and niacin for glaucoma and AMD management based on preclinical/clinical evidence.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"d926dc3baadd5fd0fe92ff25a828c8a5724ccda1db618534f121a00793a69d2e"},{"id":"s12","type":"review","url":"https://pubmed.ncbi.nlm.nih.gov/42047243/","title":"Role of nicotinamide adenine dinucleotide in cardiovascular diseases and therapeutics","quote":"This review mainly focuses on the role of NAD+ in cardiovascular diseases and therapeutics. Keywords: cardiovascular diseases; circadian ...","summary":"Review on NAD+ role in cardiovascular diseases and potential therapeutics.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"d8fd72f84963b8133618a3de1913e0ae5222e1b7d077f976e386d051653c301b"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s1","type":"review","url":"https://pubmed.ncbi.nlm.nih.gov/37971292/","title":"Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review","quote":"This review includes 10 studies, with a total of 489 participants. ... NADH supplementation is safe and has a low incidence of side effects. Future investigations are needed to evidence the clinical benefits regarding specific diseases and doses administered.","summary":"2024 systematic review of RCTs on NAD+/NADH supplementation safety and efficacy across conditions like CFS, Parkinson's, Alzheimer's; concludes well-tolerated with some benefits in quality of life and parameters, low side effects.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"869513647d4f7588142f478728e329e0365fdb47c4097d349c753f32df3e7491"},{"id":"s2","type":"review","url":"https://pubmed.ncbi.nlm.nih.gov/41655607/","title":"NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence","quote":"We identified 113 eligible studies: 33 human intervention studies (28 randomized; 5 nonrandomized) and 80 rodent studies. ... Overall, NAD⁺ augmentation shows clear biological activity, but clinical effectiveness for anti-aging or wellness outcomes remains inconclusive.","summary":"2026 PRISMA systematic review of 113 studies (up to Oct 2025) on NAD+ precursors; strong preclinical effects, human trials show NAD boosting and tolerability but heterogeneous/inconclusive functional outcomes; calls for larger trials.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"822ba9e2aaf73280d08236720d9f832a0e3ee3a82123407d5eae116d49166b00"},{"id":"s3","type":"clinical_trial","url":"https://pubmed.ncbi.nlm.nih.gov/40479886/","title":"Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial","quote":"Preliminary results indicate a positive trend in peripheral endothelial function, significant improvements in cerebrovascular response in the left dorsolateral prefrontal cortex, and cognitive enhancement across multiple domains postsupplementation. ... These findings suggest that NR supplementation could ameliorate cognitive outcomes in older adults with PAD.","summary":"2025 pilot open-label trial (NCT06534944) of NR in 8 older PAD patients; showed trends/improvements in endothelial function, cerebrovascular responses, cognition, and in vitro endothelial benefits via reduced oxidative stress.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"a7eac5f034f16239c03d81c53c53248fddebba7aae23d702345e12aa1a77e5c6"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40954388/","title":"Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial","quote":"This study has confirmed that supplementation with NAD+ can enhance cardiac function in patients with from HF due to ICM, thereby affirming its beneficial impact on cardiac performance.","summary":"2026 RCT showing IV NAD+ improves LVEF and trends toward better outcomes in heart failure patients.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"157174255e4fcde7e87c20f630ec7e13746a109becc869b702de1747b9747c38"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41540253/","title":"The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans","quote":"Here we show in a randomized, open-label, placebo-controlled study in 65 healthy participants that 14 days of supplementation with NR and NMN, but not Nam, comparably increases circulatory NAD + concentrations in healthy adults.","summary":"2026 RCT comparing NR, NMN, and Nam effects on NAD levels and gut microbiota.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"e8af32efc5694522778f2a43384a68b781f822f1bc3a5be7610b71d54d109208"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41083806/","title":"NAD+ precursor supplementation in human ageing: clinical evidence and challenges","quote":"In this Review, we evaluate the clinical evidence supporting the notion that NAD + levels decline with age, as well as the tissue-specific effects of NAD + precursor supplementation in humans.","summary":"Recent review on clinical evidence for NAD+ precursors in aging.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"f6121f80d6ef9da89b1e4addb8a62c6f7ca188c454f1859a2b94f091dfe460d2"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41704678/","title":"Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting","quote":"Supplementation with NAD + and its precursors is commonly used to prevent age-related disease and extend healthspan.","summary":"2026 pilot study comparing IV NAD+ and NR tolerability.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"649a99782648d1dcc12c936eb9ea8870f24ca71ef7598348b79d1ee248e49abf"},{"id":"s8","type":"review","url":"https://pubmed.ncbi.nlm.nih.gov/39116016/","title":"Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials","quote":"Random-effects meta-analyses found an overall significant effect of NMN supplementation in elevating blood NAD levels. However, most of the clinically relevant ...","summary":"Systematic review and meta-analysis of RCTs on oral NMN for glucose and lipid metabolism in adults; shows NAD elevation but heterogeneous clinical outcomes.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"8b8b73b0fe3b838c4b95d9d4922ecdd4ef248375a0c6a15d5acd9f5167a98015"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39817194/","title":"Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment","quote":"Eight weeks NR supplementation is safe and lowered pTau 217 concentrations but did not alter cognition as measured by conventional or novel digital assessments.","summary":"Double-blind RCT showing 8 weeks NR safe, lowers AD biomarker pTau217, no cognitive change in older adults with SCD/MCI.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"fa06e720a34103e64fe25080eb218c55950cc759dbc473a9636a8d6f1bf359d6"},{"id":"s10","type":"clinical_trial","url":"https://pubmed.ncbi.nlm.nih.gov/40770531/","title":"Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial","quote":"This pilot randomized clinical trial (RCT) tested the efficacy of combining aerobic exercise with the NAD booster nicotinamide riboside (NR) to enhance BP ...","summary":"Pilot RCT of NR plus aerobic exercise for hypertension in middle-aged/older adults; tests efficacy for BP control.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"6c843db930a5bc943911b6b596d9262c48b6e8a04dacccf51850f6a49ea5fdd7"},{"id":"s11","type":"review","url":"https://pubmed.ncbi.nlm.nih.gov/39203931/","title":"NAD+ and Niacin Supplementation as Possible Treatments for Glaucoma and Age-Related Macular Degeneration: A Narrative Review","quote":"This review investigates the potential therapeutic benefits of NAD+ and niacin supplementation in managing glaucoma and AMD.","summary":"Narrative review on NAD+ and niacin for glaucoma and AMD management based on preclinical/clinical evidence.","claim_ids":[],"link_status":"ok","quote_status":"verified","hash":"d926dc3baadd5fd0fe92ff25a828c8a5724ccda1db618534f121a00793a69d2e"},{"id":"s12","type":"review","url":"https://pubmed.ncbi.nlm.nih.gov/42047243/","title":"Role of nicotinamide adenine dinucleotide in cardiovascular diseases and therapeutics","quote":"This review mainly focuses on the role of NAD+ in cardiovascular diseases and therapeutics. Keywords: cardiovascular diseases; circadian ...","summary":"Review on NAD+ role in cardiovascular diseases and potential therapeutics.","claim_ids":[],"link_status":"ok","quote_status":"unverified","hash":"d8fd72f84963b8133618a3de1913e0ae5222e1b7d077f976e386d051653c301b"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"nad-plus","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":0,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":0,"claims_total":0,"sources":12,"anecdotal":0,"scientific":12,"user_reports":0,"questions":0,"evidence_ingests":0}}